How many insider declarations has Morrow Phuong Khanh filed?

Morrow Phuong Khanh has filed 3 public insider declarations with SEC (Form 4).

What is Morrow Phuong Khanh's role?

Morrow Phuong Khanh's reported role is not specified by the regulator across the filings.

Which companies does Morrow Phuong Khanh report trades for?

Morrow Phuong Khanh reports trades for 2 companies, including CRISPR Therapeutics AG.

← Executives ★ Sign in to follow

MP

Morrow Phuong Khanh

·SEC (Form 4)

CRISPR Therapeutics AG Lantheus Holdings, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Morrow Phuong Khanh. Director active across 2 companies, notably CRISPR Therapeutics AG. Cumulatively, 3 filings have been logged. History available since 7 February 2025. The latest transaction was disclosed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Morrow Phuong Khanh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

CRISPR Therapeutics AG (US)Lantheus Holdings, Inc. (US)

申报3 总计

◆

Morrow Phuong Khanh

Director高管2025年5月14日Lantheus Holdings, Inc.

0SEC ↗

2,537 股0Common StockSEC:0001062993-25-009698:0

◆

Morrow Phuong Khanh

Director高管2025年2月7日Lantheus Holdings, Inc.

0SEC ↗

563 股0Common StockSEC:0001062993-25-002103:0

◇

Morrow Phuong Khanh

Chief Medical Officer高管2023年5月23日CRISPR Therapeutics AG

0SEC ↗

6,938 股Common SharesSEC:0001209191-23-032250:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

MP

Morrow Phuong Khanh

·SEC (Form 4)

CRISPR Therapeutics AG Lantheus Holdings, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by Morrow Phuong Khanh. Director active across 2 companies, notably CRISPR Therapeutics AG. Cumulatively, 3 filings have been logged. History available since 7 February 2025. The latest transaction was disclosed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.